Bold Insight and The Office of Experience partner to deliver outstanding user experiences.
Back to team page
Kaitlin Carter
Senior UX Researcher
Kaitlin (known to many by their nickname Indy) approaches every project with the multidisciplinary lens of 5+ years of experience in both human factors and UX. Their passion lies in human factors studies, ranging from complex drug delivery systems to software as medical device (SaMD). Their research background in linguistic and business anthropology offers clients insight from various industries that can be applied to every research question. Kaitlin has a BA in Cultural Anthropology and an MA in Business and Organizational Anthropology from Wayne State University.
Bold facts
Learn more about
Something unique about you summed up in one sentence
Your favorite part of working at Bold Insight
Do you have a long-term personal or professional goal you'd like to share?
How long have you been in the UX field?
You cannot start the day without doing this...
Your favorite city in the world is...and why?
Your ultimate celebrity dinner party guest list would include:
Any other facts to share?
Read our team’s latest bold insights
When designing an experience, are you really thinking about the customer first?
While every organization has constraints to consider when designing experiences for customers or users, designing the ideal customer experience is completely possible within those constraints. Begin by identifying the experience you want your customer to have and work “backward” from there.
UX project logistics: choosing the right vendors for project success
Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.